These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 20555144)
1. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. Boyd TD; Bennett SP; Mori T; Governatori N; Runfeldt M; Norden M; Padmanabhan J; Neame P; Wefes I; Sanchez-Ramos J; Arendash GW; Potter H J Alzheimers Dis; 2010; 21(2):507-18. PubMed ID: 20555144 [TBL] [Abstract][Full Text] [Related]
2. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657 [TBL] [Abstract][Full Text] [Related]
3. The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice. Ahmed MM; Wang AC; Elos M; Chial HJ; Sillau S; Solano DA; Coughlan C; Aghili L; Anton P; Markham N; Adame V; Gardiner KJ; Boyd TD; Potter H Neurobiol Dis; 2022 Jun; 168():105694. PubMed ID: 35307513 [TBL] [Abstract][Full Text] [Related]
4. Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer's disease mice. Kiyota T; Machhi J; Lu Y; Dyavarshetty B; Nemati M; Yokoyama I; Mosley RL; Gendelman HE J Neuroimmunol; 2018 Jun; 319():80-92. PubMed ID: 29573847 [TBL] [Abstract][Full Text] [Related]
5. Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease. Manczak M; Mao P; Nakamura K; Bebbington C; Park B; Reddy PH Hum Mol Genet; 2009 Oct; 18(20):3876-93. PubMed ID: 19617638 [TBL] [Abstract][Full Text] [Related]
6. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis. Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD Front Immunol; 2020; 11():613975. PubMed ID: 33679701 [TBL] [Abstract][Full Text] [Related]
7. Granulocyte macrophage colony-stimulating factor receptor α expression and its targeting in antigen-induced arthritis and inflammation. Cook AD; Louis C; Robinson MJ; Saleh R; Sleeman MA; Hamilton JA Arthritis Res Ther; 2016 Dec; 18(1):287. PubMed ID: 27908288 [TBL] [Abstract][Full Text] [Related]
8. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066 [TBL] [Abstract][Full Text] [Related]
9. Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's disease and multiple sclerosis. Reddy PH; Manczak M; Zhao W; Nakamura K; Bebbington C; Yarranton G; Mao P J Neurochem; 2009 Dec; 111(6):1514-28. PubMed ID: 19840215 [TBL] [Abstract][Full Text] [Related]
10. Granulocyte-macrophage colony-stimulating factor is a key mediator in inflammatory and arthritic pain. Cook AD; Pobjoy J; Sarros S; Steidl S; Dürr M; Lacey DC; Hamilton JA Ann Rheum Dis; 2013 Feb; 72(2):265-70. PubMed ID: 22833372 [TBL] [Abstract][Full Text] [Related]
11. MLN51 and GM-CSF involvement in the proliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis. Jang J; Lim DS; Choi YE; Jeong Y; Yoo SA; Kim WU; Bae YS Arthritis Res Ther; 2006; 8(6):R170. PubMed ID: 17101062 [TBL] [Abstract][Full Text] [Related]
12. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372 [TBL] [Abstract][Full Text] [Related]
13. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Seymour JF; Lieschke GJ; Grail D; Quilici C; Hodgson G; Dunn AR Blood; 1997 Oct; 90(8):3037-49. PubMed ID: 9376584 [TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease. Potter H; Woodcock JH; Boyd TD; Coughlan CM; O'Shaughnessy JR; Borges MT; Thaker AA; Raj BA; Adamszuk K; Scott D; Adame V; Anton P; Chial HJ; Gray H; Daniels J; Stocker ME; Sillau SH Alzheimers Dement (N Y); 2021; 7(1):e12158. PubMed ID: 33778150 [TBL] [Abstract][Full Text] [Related]
15. MK0677, a Ghrelin Mimetic, Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology. Tian J; Wang T; Wang Q; Guo L; Du H J Alzheimers Dis; 2019; 72(2):467-478. PubMed ID: 31594237 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of namilumab, a human monoclonal antibody against granulocyte-macrophage colony-stimulating factor (GM-CSF) ligand in patients with rheumatoid arthritis (RA) with either an inadequate response to background methotrexate therapy or an inadequate response or intolerance to an anti-TNF (tumour necrosis factor) biologic therapy: a randomized, controlled trial. Taylor PC; Saurigny D; Vencovsky J; Takeuchi T; Nakamura T; Matsievskaia G; Hunt B; Wagner T; Souberbielle B; Arthritis Res Ther; 2019 Apr; 21(1):101. PubMed ID: 30999929 [TBL] [Abstract][Full Text] [Related]